United Lincolnshire Hospitals Nhs Trust

This study tests whether adding bomedemstat to the standard drug momelotinib can help people with myelofibrosis, a rare bone marrow cancer. It includes 40 adults who either did not improve enough on momelotinib alone or had low blood counts. The main goal is to see if the combina…